Your browser doesn't support javascript.
loading
Cost analysis of erlotinib versus chemotherapy for first-line treatment of non-small-cell lung cancer in frail elderly patients participating in a prospective phase 2 study (GFPC 0505).
Chouaid, Christos; Le Caer, Hervé; Corre, Romain; Crequit, Jacquy; Locher, Chrystelle; Falchero, Lionel; Dujon, Cecile; Berard, Henri; Monnet, Isabelle; Vergnenegre, Alain.
Affiliation
  • Chouaid C; AP-HP Hôpital, St-Antoine, AP-HP, UMPC, Paris, France. christos.chouaid@sat.aphp.fr
Clin Lung Cancer ; 14(2): 103-7, 2013 Mar.
Article in En | MEDLINE | ID: mdl-22682669
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinazolines / Frail Elderly / Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / ErbB Receptors / Lung Neoplasms Type of study: Clinical_trials / Health_economic_evaluation / Observational_studies Aspects: Patient_preference Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Clin Lung Cancer Journal subject: NEOPLASIAS Year: 2013 Document type: Article Affiliation country: Francia Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Quinazolines / Frail Elderly / Carcinoma, Non-Small-Cell Lung / Protein Kinase Inhibitors / ErbB Receptors / Lung Neoplasms Type of study: Clinical_trials / Health_economic_evaluation / Observational_studies Aspects: Patient_preference Limits: Aged / Aged80 / Female / Humans / Male Language: En Journal: Clin Lung Cancer Journal subject: NEOPLASIAS Year: 2013 Document type: Article Affiliation country: Francia Country of publication: Estados Unidos